Annual per U.S. user out-of-pocket expenditure on major types of asthma medications 2008-2009

Annual out-of-pocket expenditure per user on major types of asthma medications in the U.S. in 1998-1999 and 2008-2009*

by Statista Research Department, last edited Jul 15, 2012
Annual per U.S. user out-of-pocket expenditure on major types of asthma medications 2008-2009 This statistic depicts the annual per user out-of-pocket expenditure on major types of asthma medication in the United States in 1998-1999 and 2008-2009. In 1998-1999, the annual out-of-pocket expenditure for controllers per adult user amounted to 238 U.S. dollars.
Show more

Annual out-of-pocket expenditure per user on major types of asthma medications in the U.S. in 1998-1999 and 2008-2009*

You need to log in to download this statistic
Register for free
Already a member?
Log in
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Asthma in the U.S."
  • Prevalence
The most important statistics
  • Asthma attacks
  • Deaths
  • Regions and states
  • Doctors and hospitals
  • Medication
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.